Emi Takeuchi1,2, Masashi Kato3,4,5, Saho Wada5, Saran Yoshida6, Chikako Shimizu7, Yoko Miyoshi8. 1. Department of Consultation, Counseling and Support Service Center, National Cancer Center Hospital, Tokyo, Japan. etakeuch@ncc.go.jp. 2. Center of Palliative Medicine, Keio University Hospital, 5-1-1 Tsukiji, Chuo-ku, Tokyo, 104-0045, Japan. etakeuch@ncc.go.jp. 3. Department of Consultation, Counseling and Support Service Center, National Cancer Center Hospital, Tokyo, Japan. 4. Center for Cancer Control and Information Services, National Cancer Center, Tokyo, Japan. 5. Department of Psycho-oncology, National Cancer Center Hospital, Tokyo, Japan. 6. Graduate School of Education/Faculty of Education, Tohoku University, Sendai, Japan. 7. Department of Breast and Medical Oncology, National Cancer Center Hospital, Tokyo, Japan. 8. Department of Pediatrics, Osaka University School of Medicine, Osaka, Japan.
Abstract
PURPOSE: The aim of this study is to describe physicians' clinical practice of discussing fertility issues with cancer patients and determine the factors associated with such discussion. METHODS: In this cross-sectional study, a nationwide Internet survey was conducted among physicians who provided daily medical care to cancer patients at hospitals or clinics. Participants answered a questionnaire assessing characteristics, discussion practices, attitudes, and barriers regarding fertility preservation. RESULTS: Among the 180 participants, 42% discussed fertility issues with patients daily, and 30% had experience in referring patients to fertility preservation specialists. A multivariate logistic regression analysis showed that those who agreed or strongly agreed with the statements "physicians are responsible for discussing fertility preservation" (OR = 2.04, 95% CI 1.14-3.63, p < 0.05) and "patients who have an exceedingly aggressive disease and need immediate cancer treatment should not be told about fertility issues" (OR =1.84, 95% CI 1.09-3.10, p < 0.05) were nearly twice as likely to discuss fertility issues with patients. CONCLUSIONS: Compared to Western countries, fertility issues are less likely to be discussed in Japan. To increase opportunities for patients to discuss fertility issues, the ASCO guidelines should be widely understood. Additionally, these results suggest that physicians who are more likely to discuss fertility issues might feel more conflicted about whether they in fact should discuss such issues with patients with poor prognosis or insufficient time for cancer treatment.
PURPOSE: The aim of this study is to describe physicians' clinical practice of discussing fertility issues with cancerpatients and determine the factors associated with such discussion. METHODS: In this cross-sectional study, a nationwide Internet survey was conducted among physicians who provided daily medical care to cancerpatients at hospitals or clinics. Participants answered a questionnaire assessing characteristics, discussion practices, attitudes, and barriers regarding fertility preservation. RESULTS: Among the 180 participants, 42% discussed fertility issues with patients daily, and 30% had experience in referring patients to fertility preservation specialists. A multivariate logistic regression analysis showed that those who agreed or strongly agreed with the statements "physicians are responsible for discussing fertility preservation" (OR = 2.04, 95% CI 1.14-3.63, p < 0.05) and "patients who have an exceedingly aggressive disease and need immediate cancer treatment should not be told about fertility issues" (OR =1.84, 95% CI 1.09-3.10, p < 0.05) were nearly twice as likely to discuss fertility issues with patients. CONCLUSIONS: Compared to Western countries, fertility issues are less likely to be discussed in Japan. To increase opportunities for patients to discuss fertility issues, the ASCO guidelines should be widely understood. Additionally, these results suggest that physicians who are more likely to discuss fertility issues might feel more conflicted about whether they in fact should discuss such issues with patients with poor prognosis or insufficient time for cancer treatment.
Entities:
Keywords:
Attitude; Barrier; Cancer survivor; Discussion; Fertility
Authors: A Overbeek; M van den Berg; L Louwé; E Wendel; M ter Kuile; G Kaspers; A Stiggelbout; E van Dulmen-Den Broeder; C Hilders Journal: Neth J Med Date: 2014-06 Impact factor: 1.422
Authors: Stephanie J Lee; Leslie R Schover; Ann H Partridge; Pasquale Patrizio; W Hamish Wallace; Karen Hagerty; Lindsay N Beck; Lawrence V Brennan; Kutluk Oktay Journal: J Clin Oncol Date: 2006-05-01 Impact factor: 44.544
Authors: Gwendolyn P Quinn; Susan T Vadaparampil; Ji-Hyun Lee; Paul B Jacobsen; Gerold Bepler; Johnathan Lancaster; David L Keefe; Terrance L Albrecht Journal: J Clin Oncol Date: 2009-10-13 Impact factor: 44.544
Authors: A W Loren; R Brazauskas; E J Chow; M Gilleece; J Halter; D A Jacobsohn; S Joshi; J Pidala; G P Quinn; Z Wang; J F Apperley; L J Burns; G A Hale; B M Hayes-Lattin; R Kamble; H Lazarus; P L McCarthy; V Reddy; A B Warwick; B J Bolwell; C Duncan; G Socie; M L Sorror; J R Wingard; N S Majhail Journal: Bone Marrow Transplant Date: 2013-02-18 Impact factor: 5.483
Authors: Gwendolyn P Quinn; Susan T Vadaparampil; Clement K Gwede; Cheryl Miree; Lindsey M King; Heather B Clayton; Crystal Wilson; Pamela Munster Journal: J Cancer Surviv Date: 2007-06 Impact factor: 4.062